Advertisement

Reproductive Medicine and Biology

, Volume 12, Issue 3, pp 105–110 | Cite as

Using a mild stimulation protocol combined with clomiphene citrate and recombinant follicle-stimulating hormone to determine the optimal number of oocytes needed to achieve pregnancy and reduce the concerns of patients

  • Rikikazu Sugiyama
  • Koji NakagawaEmail author
  • Yayoi Nishi
  • Yuko Ojiro
  • Hiroyasu Juen
  • Rie Sugiyama
  • Yasushi Kuribayashi
Original Article
  • 73 Downloads

Abstract

Purpose

The purpose of this study was to investigate how many oocytes are needed to achieve an adequate pregnancy rate per 1 oocyte retrieval cycle in mild ovarian stimulation.

Methods

This protocol consisted of clomiphene citrate and recombinant-follicle-stimulating hormone injection without a gonadotropin-releasing hormone-antagonist. From January 2009 through December 2010, there were 1,227 women who underwent assisted reproductive technologies treatment with mild stimulation at the Sugiyama Clinic. The overall pregnancy rate per single oocyte retrieval cycle was evaluated using both fresh and cryopreserved-and-thawed embryos according to the retrieved oocyte number.

Results

According to the retrieved oocyte number, a total of 1,227 cycles were divided into 4 groups: group A (the oocyte number <4; 433 cycles), group B (the oocyte number = 4, 5; 317 cycles), group C (the oocyte number = 6, 7; 206 cycles), and group D (the oocyte number ≥8; 271 cycles). The overall pregnancy rates for groups A, B, C, and D were 22.2, 42.9, 52.4, and 56.0 %, respectively, the rates for groups C and D were significantly higher than that for group A (p < 0.01).

Conclusions

The optimal number of retrieved oocytes proved to be between 6 and 7 for the patients who received our milder stimulation protocol and experienced no reduction in their overall pregnancy rate.

Keywords

Clomiphene citrate Mild stimulation Optimal oocyte number Overall pregnancy rate Rec-FSH 

Notes

Conflict of interest

We have no conflict of interest.

References

  1. 1.
    Poter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS. Induction of ovulation for in vitro fertilization using buserelin and gonadotrophins. Lancet. 1984;1(2):1284–5.CrossRefGoogle Scholar
  2. 2.
    Fauser BC, Devroy P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet. 2005;365:1807–16.PubMedCrossRefGoogle Scholar
  3. 3.
    Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27:170–207.PubMedCrossRefGoogle Scholar
  4. 4.
    Bodri D, Sunkara SK, Coomarasamy A. Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis. Fertil Steril. 2011;95:164–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Nakagawa K, Nishi Y, Sugiyama R, Jyuen H, Takahashi C, Ojiro Y, Kuribayashi Y, Sugiyama R. A programmed schedule of oocyte retrieval using mild ovarian stimulation (clomiphene citrate and recombinant folic: ular stimulating hormone). Reprod Med Biol. 2012;11:85–9.CrossRefGoogle Scholar
  6. 6.
    Sugiyama R, Nakagawa K, Nishi Y, Sugiyama R, Ezaki K, Inoue M. The dilemma faced by patients who undergo single embryo transfer. Reprod Med Biol. 2009;8:33–7.CrossRefGoogle Scholar
  7. 7.
    Saito H. Clinical outcomes of ART treatment in Japan 2010. Acta Obstet Gynaecol Japonica. 2012;64:2110–28.Google Scholar
  8. 8.
    Nakagawa K, Shirai A, Nishi Y, Sugiyama R, Kuribayashi Y, Sugiyama R. A study of an extremely low oxygen concentration on the development of human embryos in assisted reproductive technology. Reprod Med Biol. 2010;9:163–8.CrossRefGoogle Scholar
  9. 9.
    Nakagawa K, Yamano S, Moride N, Yamashita M, Yoshizawa M, Aono T. Effect of activation with Ca ionophore A23187 and puromycin on the development of human oocytes that failed to fertilize after intracytoplasmic sperm injection. Fertil Steril. 2001;76:148–52.PubMedCrossRefGoogle Scholar
  10. 10.
    Nakagawa K, Takahashi C, Nishi Y, Jyuen H, Sugiyama R, Kuribayashi Y, Sugiyama R. Hyaluronan-enriched transfer medium improves outcome in patients with multiple embryo transfer failures. J Assist Reprod Genet. 2012;29:679–85.PubMedCrossRefGoogle Scholar
  11. 11.
    Nakagawa K, Nishi Y, Shirai A, Sugiyama R, Kuribayashi Y, Sugiyama R, Inoue M. Elective single cleavage-stage embryo transfer need not result in lower pregnancy rates compared to double cleavage-stage embryo transfer. J Obstet Gynecol Res. 2010;36:777–82.CrossRefGoogle Scholar
  12. 12.
    Sugiyama R, Nakagawa K, Shirai A, Nishi Y, Sugiyama R, Kuribayashi Y, Inoue M. Clinical outcomes of resulting from transfer of vitrified human embryos using a new device for cryopreservation (plastic blade). J Assist Reprod Genet. 2010;27:161–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Zarek SM, Muasher SJ. Mild/minimal stimulation for in vitro fertilization: an old idea that need to be revisited. Fertil Steril. 2011;95:2449–55.PubMedCrossRefGoogle Scholar
  14. 14.
    Verberg MFG, Eijkemans MJC, Macklon NS, Heijnen EM, Baart EB, Hofmann FP, Fauser BCJM, Broekmans FJ. The clinical significance of the retrieval of a low number of oocytes following mild stimulation for IVF: a meta-analysis. Hum Reprod Update. 2009;15:5–12.PubMedCrossRefGoogle Scholar
  15. 15.
    Williams SC, Gibbons WE, Muasher SJ, Oehninger S. Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition if a gonadotropin-releasing hormone antagonist. Fertil Steril. 2002;78:1068–72.PubMedCrossRefGoogle Scholar
  16. 16.
    Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder ovarian stimulation for in vitro fertilization reduces aneuploidy in the human pre-implantation embryo: a randomized controlled trial. Hum Reprod. 2009;22:980–8.CrossRefGoogle Scholar
  17. 17.
    Pal L, Jindal S, Witt B, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89:1694–701.PubMedCrossRefGoogle Scholar
  18. 18.
    Mukaida T, Wada S, Takahashi K, Pedro PB, An TZ, Kasai M. Vitrification of human embryos based on the assessment of suitable conditions for 8-cell mouse embryos. Hum Reprod. 1998;13:2874–9.PubMedCrossRefGoogle Scholar

Copyright information

© Japan Society for Reproductive Medicine 2013

Authors and Affiliations

  • Rikikazu Sugiyama
    • 1
  • Koji Nakagawa
    • 1
    Email author
  • Yayoi Nishi
    • 1
  • Yuko Ojiro
    • 1
  • Hiroyasu Juen
    • 1
  • Rie Sugiyama
    • 2
  • Yasushi Kuribayashi
    • 2
  1. 1.Division of Reproductive MedicineSugiyama ClinicTokyoJapan
  2. 2.Center for Reproductive Medicine and EndoscopySugiyama Clinic MarunouchiTokyoJapan

Personalised recommendations